2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2024-10-1-0-53336Pharmacology<strong>Targeting the Bap1 protein of <em>Vibrio cholerae </em>for screening potent inhibitors and predicting the mutant protein stability: in silico analyses</strong><strong>Targeting the Bap1 protein of <em>Vibrio cholerae </em>for screening potent inhibitors and predicting the mutant protein stability: in silico analyses</strong>GowthamKalidasGowthamKalidasgowthamksn0406@gmail.comPranavRithish J.PranavRithish J.r.rithish22@gmail.com202410100

Background: Bap1 is reported to be a major protein in Vibrio cholerae which aids in biofilm formation. Hence, inhibition of the protein molecule can no longer support the colonization of bacteria and induction of point mutations at specific amino acid residues tend to reduce the protein stabilization. The aim of the study: To target this Bap1 structural protein for screening potent inhibitors of ligands by means of in silico analyses. Materials and methods: A total of 30 compounds divided into three groups such as synthetic antimicrobial drugs, phytochemicals and marine compounds comprising of ten ligands in each group were tested against Bap1. In addition to this, mutations were induced at GLN: 518, HIS: 520 and ASN: 679 positions to determine the stability of the mutant Bap1 protein using bioinformatic tools. Results: Of the 30 docked compounds, doxycycline, ichangin and Ageloxime D exhibited the highest binding affinities of -8.5 kcal/mol, -9.3 kcal/mol and -8.8 kcal/mol respectively from the three groups. The ADME properties show the druglikeness of the test compounds to be used for treatment procedures.&nbsp; Protein-ligand interactions were visualized which infer that both doxycycline and ichangin form five conventional hydrogen bonds while Ageloxime D could form three hydrogen bonds with different amino acid residues of the protein. Further, the van der Waals&rsquo; interactions are also found to be similar in number among doxycycline and ichangin whereas, it is less in case of Ageloxime D but, the &pi;- interactions are high in this compound comparatively. The carbon-hydrogen bonding for these three compounds with the amino acid residues of the Bap1 protein have also been discussed. Conclusion: Thus, natural compounds can eventually replace the over use of synthetic drugs as antibiofilm agents. Also, inducing point mutations to this protein can potentially destabilize its structure

Background: Bap1 is reported to be a major protein in Vibrio cholerae which aids in biofilm formation. Hence, inhibition of the protein molecule can no longer support the colonization of bacteria and induction of point mutations at specific amino acid residues tend to reduce the protein stabilization. The aim of the study: To target this Bap1 structural protein for screening potent inhibitors of ligands by means of in silico analyses. Materials and methods: A total of 30 compounds divided into three groups such as synthetic antimicrobial drugs, phytochemicals and marine compounds comprising of ten ligands in each group were tested against Bap1. In addition to this, mutations were induced at GLN: 518, HIS: 520 and ASN: 679 positions to determine the stability of the mutant Bap1 protein using bioinformatic tools. Results: Of the 30 docked compounds, doxycycline, ichangin and Ageloxime D exhibited the highest binding affinities of -8.5 kcal/mol, -9.3 kcal/mol and -8.8 kcal/mol respectively from the three groups. The ADME properties show the druglikeness of the test compounds to be used for treatment procedures.&nbsp; Protein-ligand interactions were visualized which infer that both doxycycline and ichangin form five conventional hydrogen bonds while Ageloxime D could form three hydrogen bonds with different amino acid residues of the protein. Further, the van der Waals&rsquo; interactions are also found to be similar in number among doxycycline and ichangin whereas, it is less in case of Ageloxime D but, the &pi;- interactions are high in this compound comparatively. The carbon-hydrogen bonding for these three compounds with the amino acid residues of the Bap1 protein have also been discussed. Conclusion: Thus, natural compounds can eventually replace the over use of synthetic drugs as antibiofilm agents. Also, inducing point mutations to this protein can potentially destabilize its structure

Bap1in silico analysesbinding affinityichanginantibiofilm agentsmutant protein stabilityBap1in silico analysesbinding affinityichanginantibiofilm agentsmutant protein stabilityСписок литературыYin W, Wang Y, Liu L, et al. Biofilms: The Microbial &ldquo;Protective Clothing&rdquo; in Extreme Environments. International Journal of Molecular Sciences. 2019;20(14):3423. DOI: https://doi.org/10.3390/ijms20143423Khatoon Z, McTiernan CD, Suuronen EJ, et al. Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention. Heliyon. 2018;4(12):1067. DOI: https://doi.org/10.1016/j.heliyon.2018.e01067Reidl J, Klose KE. Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiology Reviews. 2002;26(2):125-139. DOI: https://doi.org/10.1111/j.1574-6976.2002.tb00605.xLekshmi N, Joseph I, Ramamurthy T, et al. Changing facades of vibrio cholerae: An enigma in the epidemiology of cholera. Indian Journal of Medical Research. 2018;147(2):133-141. DOI: https://doi.org/10.4103/ijmr.IJMR_280_17Duperthuy M, Sj&ouml;str&ouml;m AE, Sabharwal D, et al. Role of the Vibrio cholerae Matrix Protein Bap1 in Cross-Resistance to Antimicrobial Peptides. PLoS Pathogens. 2013;9(10):e1003620. DOI: https://doi.org/10.1371/journal.ppat.1003620Katsila T, Spyroulias GA, Patrinos GP, et al. Computational approaches in target identification and drug discovery. Computational and Structural Biotechnology Journal. 2016;14:177-184. DOI: https://doi.org/10.1016/j.csbj.2016.04.004Sanavia T, Birolo G, Montanucci L, et al. Limitations and challenges in protein stability prediction upon genome variations: towards future applications in precision medicine. Computational and Structural Biotechnology Journal. 2020;18:1968-1979. DOI: https://doi.org/10.1016/j.csbj.2020.07.011Kaus K, Biester A, Chupp E, et al. The 1.9&Aring; crystal structure of the extracellular matrix protein Bap1 from Vibrio cholerae provides insights into bacterial biofilm adhesion. Journal of Biological Chemistry. 2019;294(40):14499-14511. DOI: https://doi.org/10.1074/jbc.RA119.008335Mishra R, Panda AK, de Mandal S, et al. Natural Anti-biofilm Agents: Strategies to Control Biofilm-Forming Pathogens. Frontiers in Microbiology. 2020;11:2640. DOI: https://doi.org/10.3389/fmicb.2020.566325Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera&mdash;A visualization system for exploratory research and analysis. Journal of Computational Chemistry. 2004;25(13):1605-1612. DOI: https://doi.org/10.1002/jcc.20084Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry. 2010;31(2):455-461. DOI: https://doi.org/10.1002/jcc.21334Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports. 2017;7(1):42717. DOI: https://doi.org/10.1038/srep42717Parthiban V, Gromiha MM, Schomburg D. CUPSAT: prediction of protein stability upon point mutations. Nucleic Acids Research. 2006;34(2):W239-W242. DOI: https://doi.org/10.1093/nar/gkl190Kabir ER, Mustafa N, Nausheen N, et al. Exploring existing drugs: proposing potential compounds in the treatment of COVID-19. Heliyon. 2021;7(2):e06284. DOI: https://doi.org/10.1016/j.heliyon.2021.e06284Degfie T, Endale M, Tafese T, et al. In vitro antibacterial, antioxidant activities, molecular docking, and ADMET analysis of phytochemicals from roots of Hydnora johannis. Applied Biological Chemistry. 2022;65:76. DOI: https://doi.org/10.1186/s13765-022-00740-8Lahiri D, Nag M, Dey S, et al. Phytocompounds of Curcuma longa extract are more effective against bacterial biofilm than pure curcumin only: An in-vitro and in-silico analysis. Kuwait Journal of Science. 2021;48(2):8310. DOI: https://doi.org/10.48129/kjs.v48i2.8310Murugesan S, Ragavendran C, Ali A, et al. Screening and Druggability Analysis of Marine Active Metabolites against SARS-CoV-2: An Integrative Computational Approach. Journal of Translational Medicine. 2023;3(1):27-41. DOI: https://doi.org/10.3390/ijtm3010003Giofr&egrave; SV, Napoli E, Iraci N, et al. Interaction of selected terpenoids with two SARS-CoV-2 key therapeutic targets: An in silico study through molecular docking and dynamics simulations. Computers in Biology and Medicine. 2021;134:104538. DOI: https://doi.org/10.1016/j.compbiomed.2021.104538Lu L, Hu W, Tian Z, et al. Developing natural products as potential anti-biofilm agents. Chinese Medicine. 2019;14:11. DOI: https://doi.org/10.1186/s13020-019-0232-2Stan D, Enciu AM, Mateescu AL, et al. Natural Compounds With Antimicrobial and Antiviral Effect and Nanocarriers Used for Their Transportation. Frontiers in Pharmacology. 2021;12:723233. DOI: https://doi.org/10.3389/fphar.2021.723233Vikram A, Jesudhasan PR, Pillai SD, et al. Isolimonic acid interferes with Escherichia coli O157:H7 biofilm and TTSS in QseBC and QseA dependent fashion. BMC Microbiology. 2012;12:261. DOI: https://doi.org/10.1186/1471-2180-12-261Basak HK, Saha S, Ghosh J, et al. Sequence Analysis, Structure Prediction of Receptor Proteins and In Silico Study of Potential Inhibitors for Management of Life Threatening COVID-19. Letters in Drug Design and Discovery. 2021;19(2):108-122. DOI: https://doi.org/10.2174/1570180818666210804141613Yeom JH, Kim HY, Lim JH, et al. A calcium channel blocker, manoalide exerts an anti-allergic inflammatory effect through attenuating NF-&kappa;B activity. Immunopharmacology and Immunotoxicology. 2021;43(6):799-805. DOI: https://doi.org/10.1080/08923973.2021.1988101Han BN, Hong LL, Gu BB, et al. Natural Products from Sponges. In: Li Z, editor. Symbiotic Microbiomes of Coral Reefs Sponges and Corals. Springer; 2019:329-463. DOI: https://doi.org/10.1007/978-94-024-1612-1Imchen M, Moopantakath J, Kumavath R, et al. Current Trends in Experimental and Computational Approaches to Combat Antimicrobial Resistance. Frontiers in Genetics. 2020;11:563975. DOI: https://doi.org/10.3389/fgene.2020.563975Ayaz M, Ullah F, Sadiq A, et al. Synergistic interactions of phytochemicals with antimicrobial agents: Potential strategy to counteract drug resistance. Chemico-Biological Interactions. 2019;308:294-303. DOI: https://doi.org/10.1016/j.cbi.2019.05.050Melander RJ, Basak AK, Melander C. Natural products as inspiration for the development of bacterial antibiofilm agents. Natural Product Reports. 2020;37(11):1454-1477. DOI: https://doi.org/10.1039/D0NP00022AMalik JK, Nautiyal B, Kumar A. Doxycycline as potent inhibitor of COVID-19 main protease: in-silico docking approach. European Journal of Biomedical and Pharmaceutical Sciences. 2020;7(10):400-405.Anthappagudem A, Enaganti S, Bhukya B. Integration of mutational and molecular docking studies: An in silico approach to assess the stability and binding potential of CYP3A4. Journal of Applied Biology and Biotechnology. 2022;11(1):161-170. DOI: https://doi.org/10.7324/JABB.2023.110122Benvenuto D, Benedetti F, Demir AB, et al. Analysis of Three Mutations in Italian Strains of SARS-CoV-2: Implications for Pathogenesis. Chemotherapy. 2021;66(1-2):33-37. DOI: https://doi.org/10.1159/000515342Gowtham K, Pranav RJ. Milk dependent hemagglutination inhibition and calcium alginate immobilization of ricin isolated from Ricinus communis L. seeds. Journal of Biological Studies. 2022;5(4):705-713.